HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of a blood group antigen precursor in oral premalignant lesions.

Abstract
Epithelial cell membrane-bound blood group antigens A and B are lost in premalignant and malignant oral lesions. We now show that this loss in premalignant lesions is accompanied by accumulation of a blood group antigen precursor. The precursor structures were: type 2 chain H-antigen, Fuc alpha 1 leads to 2 Gal beta 1 leads to 4 GlcNAc-R (A and B precursor); and N-acetyllactosamine, Gal beta 1-4GlcNAc-R (H-precursor), in which Fuc is L-fucose, Gal is galactose, and GIcNAc is N-acetyl-D-glucosamine. They were demonstrated in tissue sections by immunohistochemical staining techniques with monoclonal antibodies to H-antigen and N-acetyllactosamine. Precursors were found only on basal and suprabasal cells of normal mucosa. In all nine of ten premalignant lesions, the H-antigen was found on all cell membranes in the epithelium, in higher titers than in normal adjacent epithelium. Ten carcinomas were studied, and all showed an irregular distribution of H-antigen. N-Acetyllactosamine was not found in premalignant or malignant lesions. The accumulation of type 2 chain H-antigen in oral premalignant lesions may prove helpful in early diagnosis of epithelial cancer.
AuthorsE Dabelsteen, P Vedtofte, S Hakomori, W W Young Jr
JournalCancer research (Cancer Res) Vol. 43 Issue 3 Pg. 1451-4 (Mar 1983) ISSN: 0008-5472 [Print] United States
PMID6825113 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ABO Blood-Group System
  • Amino Sugars
  • Antibodies
  • N-acetyllactosamine
Topics
  • ABO Blood-Group System (immunology)
  • Amino Sugars (immunology)
  • Antibodies (analysis)
  • Carcinoma, Squamous Cell (immunology)
  • Humans
  • Mouth Neoplasms (immunology)
  • Precancerous Conditions (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: